Navigation Links
Immunoglobulin Market (PI & CIDP ) Analysis and Forecasts to 2019 in New Research Report at ReportsnReports.com
Date:5/27/2013

Dallas, Texas (PRWEB) May 27, 2013

“Immunoglobulins Market to 2019 Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer’s Disease” provides in-depth analysis of the global immunoglobulin market. The report analyzes the markets for immunoglobulin products in the US, the top five European countries (the UK, Germany, France, Italy and Spain) and Japan. The revenue and annual cost of therapy are forecast for the key geographies and in seven key therapeutic segments, along with epidemiological data, until 2019. The seven key therapeutic segments are Primary Immunodeficiency (PI), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Multifocal Motor Neuropathy (MMN), Guillain-Barré Syndrome (GBS), Myasthenia Gravis (MG), Idiopathic Thrombocytopenic Purpura (ITP), and Chronic Lymphocytic Leukemia (CLL). The report (http://www.reportsnreports.com/reports/239437-immunoglobulins-market-to-2019-demand-in-primary-immunodeficiency-pi-and-chronic-inflammatory-demyelinating-polyneuropathy-cidp-potentially-supplemented-by-approvals-for-alzheimers-disease.html) also profiles the marketed products, key pipeline products, and leading companies that could change the market landscape in the forecast period.

The report expects the immunoglobulin market to see a slight increase in its growth rate during the 2012–2019 forecast period. It was worth $3.6 billion in 2012, having grown at a Compound Annual Growth Rate (CAGR) of 6% from 2006. Demand for immunoglobulin products continues to increase due to growing disease awareness and therapeutic usage in a wide range of therapeutic areas. Immunology and neurology are the disciplines that use the most immunoglobulins, while PI and CIDP are the top indications. Geographically, the US is the largest market, commanding a share of over 70% of the global market. 11 new products have been approved in the US since 2006, but as many are for PI or ITP, immunoglobulin usage in the US remains off-label for all other indications.

Baxter, CSL Behring, and Grifols continue to command the top ranks in terms of revenue, and recent approvals of Subcutaneous Immunoglobulins (SCIGs) in the US and Europe will further boost market growth.

Scope

  •     Annualized market data for the immunoglobulin market from 2006 to 2012 and forecast to 2019
  •     Analysis of the seven key therapeutic segments: PI, CIDP, MMN, MG, CLL, GBS and ITP
  •     Analysis of the immunoglobulins markets in the leading global geographies: the US, the top five European countries, and Japan
  •     Market characterization of the immunoglobulin market, covering size, revenue analysis by geography, the annual cost of therapy, and epidemiology
  •     Key drivers and barriers that have a significant impact on the market
  •     Coverage of key marketed products, approved indications, and safety and efficacy profiles
  •     Coverage of the pipeline molecules in various phases of drug development
  •     Competitive profiling of the leading companies: Baxter, Biotest, Bio Products Laboratory, CSL Behring, Grifols, and Octapharma
  •     Key M&A activity and licensing agreements between 2012 and mid-2013 in the global immunoglobulin market
  •     Overview of the immunoglobulin markets in Asia-Pacific and China, covering regulations, key players and marketed products

Reasons To Buy

  •     Align your product portfolio to the markets with high growth potential
  •     Develop market-entry and market-expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
  •     Develop key strategic initiatives by understanding the key focus areas of the leading companies
  •     Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=239437.

Immunoglobulins Market to 2019 - Profiles of Marketed Products:
1.    Privigen
2.    Gammagard S/D
3.    Gammagard Liquid
4.    Octagam 5%
5.    Flebogamma 10% DIF
6.    Gamunex-C
7.    Gammaplex
8.    HyQvia
9.    Bivigam

Explore more reports on Pharmaceuticals Market @ http://www.reportsnreports.com/market-research/pharmaceuticals/.

About US:
ReportsnReports.com (http://www.reportsnreports.com/) is an online market research reports library of 200,000+ reports and in-depth studies of 5000+ micro markets. Our database includes reports by leading publishers from across the globe.

Read the full story at http://www.prweb.com/releases/immunoglobulin-market/pi-cidp-analysis-2019/prweb10772086.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency And CIDP Potentially Supplemented by Approval for Alzheimers Disease Available at ResearchMoz.us
2. Majority of states fail to address youth exposure to alcohol marketing
3. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
4. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
5. New Report Video Surveillance Market (2011 – 2016) by MarketsandMarkets
6. Dotcomsecrets is Offering New Opportunities to People Who Want to Become Expert in Localized Internet Marketing
7. 101 Mobility Opens Franchise in Roanoke/Lynchburg Market
8. How MyTownInsurance.com Helps Insurance Carriers Manage their Loss Exposure through On-Line Marketing
9. Discount Supermarkets Tied to Rising Obesity Rates
10. DotComSecrets Invites Professionals to Learn Great Tips On How to Make a Handsome Income By Working As Local Internet Marketing Consultants
11. Heavy Duty Alternators and Starters Expert Elreg Distributors Ltd. Meets Needs of International Market with Launch of Spanish Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 08, 2016 , ... According to research by the National ... technicians to be certified or obtain continuing education. To increase patient awareness of ... Your Mouth?” campaign to inform dentists and patients about the possible lack of ...
(Date:2/7/2016)... ... February 07, 2016 , ... HealthSmart Holdings, Inc. announced today ... the tools and information to lower the costs, and increase the impact of ... providing employee healthcare benefits by as much as 22%:, + Price and ...
(Date:2/6/2016)... ... ... US Sports Camps is proud to sponsor the Bay Area Disc Association's ... leaders, ultimate organizations, and coaches from around the US. The theme for this year’s ... of Youth and Education, describes this year YUCC as “an important conversation we must ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... eating disorder treatment helps to reduce the frequency and level of relapse. ... Phase: Re-Establishing Healthy Identity and Purpose,” will explore the critical tasks of the ...
(Date:2/5/2016)... ... 2016 , ... VeloReality President and co-founder Gary ... VR Indoor Trainer with multi-rider capability to an enthusiastic audience at the company's ... the weight of the unit, they also enhance the rider's experience with a ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016 Vestagen Technical Textiles, Inc., a medical ... healthcare and other demanding applications, today announced it has ... replaces Dale Pfost , PhD, who was serving ... also joining Vestagen,s Board of Directors. ® ... barrier technologies that combines fluid repellent, antimicrobial and breathability ...
(Date:2/8/2016)... Ill. , Feb. 8, 2016  Astellas Pharma Inc. ... announced the promotion of James Robinson as president, ... company,s operations in North and South America ... Astellas Pharma US, representing the commercial organization in ... in 2013. Masao Yoshida , who is ...
(Date:2/8/2016)... , Feb. 8, 2016  CTI BioPharma Corp. ... Company received written communication from the U.S. Food and ... FDA has placed a partial clinical hold on the ... Drug ("IND") application for pacritinib. This clinical hold impacts ... the IND and will also affect planned clinical trials. ...
Breaking Medicine Technology: